Evaluating complications in cancer patients with neutropenic fever for home care
A Descriptive Study of Major Complications in Oncology Patients With Neutropenic Fever Potentially Eligible for a Hospital at Home Program
This study looks at cancer patients with neutropenic fever to see how often they face serious complications when treated at home instead of in the hospital.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 126 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT04557709 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the rate of major complications in cancer patients who may be eligible for a 'hospital at home' program for managing neutropenic fever. The primary objective is to estimate the complication rate among these patients, while secondary objectives include describing their demographic and clinical characteristics and identifying treatments that may be challenging to deliver at home. The study involves a review of patients' medical charts from those admitted to MD Anderson Cancer Center with neutropenic fever. Insights gained could inform the development of future home care programs.
Who should consider this trial
Good fit: Ideal candidates are cancer patients admitted with neutropenic fever who are at low risk for major complications.
Not a fit: Patients residing in nursing homes, experiencing homelessness, enrolled in hospice, or with high-risk clinical features may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management of neutropenic fever in cancer patients, allowing for safer and more comfortable home care options.
How similar studies have performed: While the concept of hospital at home programs is gaining traction, this specific approach to managing neutropenic fever in cancer patients is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Admitted to MD Anderson Cancer Center through the Emergency Center with a diagnosis of neutropenic fever between 1/1/2019 and 12/31/2019 * Be at low risk for major complications as defined by a Multinational Association for Supportive Care in Cancer (MASCC) score \< 21 Exclusion Criteria: * Reside in a nursing home * Homelessness * Hospice enrollment * A secondary reason for admission to the hospital or high risk clinical feature not captured in the MASCC score that places them at high risk for major complications in a hospital at home program
Where this trial is running
Houston, Texas
- M D Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Tacara N Soones — M.D. Anderson Cancer Center
- Study coordinator: Tacara N Soones
- Email: tnsoones@mdanderson.org
- Phone: 713-792-4253
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.